Attitudes of Israeli gynecologists towards risk reduction salpingo-oophorectomy at hysterectomy for benign conditions and the use of hormonal therapy

被引:1
作者
Assaf, Wissam [1 ,2 ]
Andraous, Marah [2 ]
Lavie, Ofer [1 ,2 ]
Segev, Yakir [1 ,2 ]
机构
[1] Lady Davis Carmel Med Ctr, Dept Obstet & Gynecol, Haifa, Israel
[2] Technion Israel Inst Technol, Rappaport Fac Med, Haifa, Israel
关键词
Hysterectomy; Risk reduction bilateral salpingo-ophorectomy; Hormonal therapy; OVARIAN CONSERVATION; BILATERAL OOPHORECTOMY; REPLACEMENT THERAPY; CANCER STATISTICS; YOUNG-WOMEN; TIME; MENOPAUSE;
D O I
10.1016/j.ejogrb.2022.03.017
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Objectives: To investigate the perspectives and attitudes of gynecologists towards risk reduction bilateral salpingo-oophorectomy (RRBSO) in average-risk women at the time of hysterectomy procedure for benign indications divided by age groups, and whether they recommend the use of hormonal therapy post oophorectomy.Methods: A questionnaire was distributed during staff meetings either by a printed questionnaire or by a link to a total number of 360 gynecologists include seniors and practitioners. Three hundred and one gynecologists participated in a national survey.Participants completed a structured questionnaire including three different scenarios.The subject group included both attending (senior) and second-year and above resident gynecologists, from divergent subspecialties. The demographic information of the survey responders included sex, age, years of experience, working domain, and subspecialty.Results: There was a 95% consensus rate among Israeli gynecologists, in favor of the ovarian conservation approach among 45-year-old women, elected for hysterectomy due to benign indications. Whereas in 50-year-old perimenopause women, without any evident family history of ovarian cancer, 39% of gynecologists advocated BSO at the time of hysterectomy, for benign indications. As for 46-year-old women, with a first-degree relative diagnosed with ovarian cancer at the age of 65 years old, 70.4% voted for prophylactic BSO.For the second part of the questionnaire regarding the utilization of hormone therapy (HT) after BSO, 66.1% of our responders proclaimed they would always encourage the use of HT in 45-year-old-women, while 52.8% recommended HT in 46-year-old-women with a family history of ovarian cancer and 39.5% for 50-year-old perimenopause women.Conclusion: Our national survey confirms the wide variability in attitudes among gynecologists towards per-forming RRBSO at hysterectomy for a benign indication in women aged 45-50, with family history being a major factor in the decision.
引用
收藏
页码:48 / 54
页数:7
相关论文
共 29 条
  • [1] Ovarian conservation vs removal at the time of benign hysterectomy
    Adelman, Marisa R.
    Sharp, Howard T.
    [J]. AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2018, 218 (03) : 269 - 279
  • [2] Breast cancer risk after hysterectomy with and without salpingo-oophorectomy for benign indications
    Chow, Stephanie
    Raine-Bennett, Tina
    Samant, Navendu D.
    Postlethwaite, Debbie A.
    Holzapfel, Marie
    [J]. AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2020, 223 (06) : 900.e1 - 900.e7
  • [3] Genetic/Familial High-Risk Assessment: Breast, Ovarian, and Pancreatic, Version 2.2021
    Daly, Mary B.
    Pal, Tuya
    Berry, Michael P.
    Buys, Saundra S.
    Dickson, Patricia
    Domchek, Susan M.
    Elkhanany, Ahmed
    Friedman, Susan
    Goggins, Michael
    Hutton, Mollie L.
    Karlan, Beth Y.
    Khan, Seema
    Klein, Catherine
    Kohlmann, Wendy
    Kurian, Allison W.
    Laronga, Christine
    Litton, Jennifer K.
    Mak, Julie S.
    Menendez, Carolyn S.
    Merajver, Sofia D.
    Norquist, Barbara S.
    Offit, Kenneth
    Pederson, Holly J.
    Reiser, Gwen
    Senter-Jamieson, Leigha
    Shannon, Kristen Mahoney
    Shatsky, Rebecca
    Visvanathan, Kala
    Weitzel, Jeffrey N.
    Wick, Myra J.
    Wisinski, Kari B.
    Yurgelun, Matthew B.
    Darlow, Susan D.
    Dwyer, Mary A.
    [J]. JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2021, 19 (01): : 77 - 102
  • [4] Hypoactive sexual desire disorder in menopausal women: A survey of western European women
    Dennerstein, L
    Koochaki, P
    Barton, I
    Graziottin, A
    [J]. JOURNAL OF SEXUAL MEDICINE, 2006, 3 (02) : 212 - 222
  • [5] Attitudes of Italian gynaecologists towards prophylactic oophorectomy at hysterectomy for non-malignant conditions
    Fuso, L
    Mazzola, S
    Ferrero, A
    Magistris, A
    Jacomuzzi, ME
    Carus, AP
    Dompè, D
    Marocco, F
    Logrippo, V
    Zola, P
    [J]. EUROPEAN JOURNAL OF OBSTETRICS & GYNECOLOGY AND REPRODUCTIVE BIOLOGY, 2006, 124 (01) : 82 - 87
  • [6] Hormone Replacement Therapy Prescription after Premature Surgical Menopause
    Garg, Nisha
    Behbehani, Sadikah
    Kosiorek, Heidi
    Wasson, Megan
    [J]. JOURNAL OF MINIMALLY INVASIVE GYNECOLOGY, 2020, 27 (07) : 1618 - 1623
  • [7] Ovarian removal at or after benign hysterectomy and breast cancer: a nationwide cohort study
    Gottschau, Mathilde
    Kjer, Susanne K.
    Settnes, Annette
    Aalborg, Gitte Lerche
    Bens, Annet
    Jensen, Allan
    Munk, Christian
    Menemkjar, Lene
    [J]. BREAST CANCER RESEARCH AND TREATMENT, 2020, 181 (02) : 475 - 485
  • [8] Does bilateral salpingectomy with ovarian retention warrant consideration as a temporary bridge to risk-reducing bilateral oophorectomy in BRCA1/2 mutation carriers?
    Greene, Mark H.
    Mai, Phuong L.
    Schwartz, Peter E.
    [J]. AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2011, 204 (01) : 19.e1 - 19.e6
  • [9] Vascular Effects of Early versus Late Postmenopausal Treatment with Estradiol
    Hodis, Howard N.
    Mack, Wendy J.
    Henderson, Victor W.
    Shoupe, Donna
    Budoff, Matthew J.
    Hwang-Levine, Juliana
    Li, Yanjie
    Feng, Mei
    Dustin, Laurie
    Kono, Naoko
    Stanczyk, Frank Z.
    Selzer, Robert H.
    Azen, Stanley P.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2016, 374 (13) : 1221 - 1231
  • [10] Ovarian cancer screening and mortality in the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS): a randomised controlled trial
    Jacobs, Ian J.
    Menon, Usha
    Ryan, Andy
    Gentry-Maharaj, Aleksandra
    Burnell, Matthew
    Kalsi, Jatinderpal K.
    Amso, Nazar N.
    Apostolidou, Sophia
    Benjamin, Elizabeth
    Cruickshank, Derek
    Crump, Danielle N.
    Davies, Susan K.
    Dawnay, Anne
    Dobbs, Stephen
    Fletcher, Gwendolen
    Ford, Jeremy
    Godfrey, Keith
    Gunu, Richard
    Habib, Mariam
    Hallett, Rachel
    Herod, Jonathan
    Jenkins, Howard
    Karpinskyj, Chloe
    Leeson, Simon
    Lewis, Sara J.
    Liston, William R.
    Lopes, Alberto
    Mould, Tim
    Murdoch, John
    Oram, David
    Rabideau, Dustin J.
    Reynolds, Karina
    Scott, Ian
    Seif, Mourad W.
    Sharma, Aarti
    Singh, Naveena
    Taylor, Julie
    Warburton, Fiona
    Widschwendter, Martin
    Williamson, Karin
    Woolas, Robert
    Fallowfield, Lesley
    McGuire, Alistair J.
    Campbell, Stuart
    Parmar, Mahesh
    Skates, Steven J.
    [J]. LANCET, 2016, 387 (10022) : 945 - 956